Ahmed, M., Tuckwell, K., Xu, M., Cheng, X., Redington, E., Koyani, B., Mateo, K., Thakur, M., Devalaraja-Narashimha, K., Morton, L., Olenchock, B., Herman, G., Wynne, C., Marin, E. (2025). Abstract 4359840: A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal Antibody. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4359840